Skip to main content
. 2021 Mar 4;22(5):2586. doi: 10.3390/ijms22052586

Table 4.

Major treatment options for symptom control in pediatric mastocytosis.

Systems and Symptoms First-Line Therapy Other Therapeutic Options
Skin: pruritus flushing, blistering HR1-antagonists HR2-antagonists
Oral corticosteroids (short course)
Topical corticosteroids
(class 1–3, short cycles ± occlusion)
Leukotriene antagonist
Pimecrolimus cream
Topical sodium cromolyn
Excision (for mastocytoma)
NB-UVB * or PUVA **
Local care (for blistering)
Gastrointestinal: diarrhea, abdominal cramping/pain, reflux, ulceration HR2-antagonists Proton pump inhibitors
Oral sodium cromolyn
Oral corticosteroids
Neuro/psychiatric: headache, poor concentration, cognitive impairment HR1 and HR2-antagonists Neuro/psychiatric treatment specific for the individual patient according to symptoms
Cardiovascular: presyncope, syncope, hypotension HR1 and HR2-antagonists Oral corticosteroids
Epinephrine
Osteopenia/osteoporosis Calcium, vitamin D3 Treatment specific for the individual patient according to the age and T-score
Anaphylaxis Epinephrine Acute anaphylaxis:
HR1 and HR2-antagonists
Oral corticosteroids
Intravenous fluids
Prevention of anaphylaxis:
Epinephrine auto-injector
HR1-antagonists
Allergen specific immunotherapy
(typically Hymenoptera venom)
Omalizumab (for recurrent episodes)

* NB-UVB—narrow-band ultraviolet B; ** PUVA—psoralen plus ultraviolet A.